GE HealthCare Technologies (GEHC) Income from Non-Controlling Interests (2022 - 2026)
GE HealthCare Technologies (GEHC) posted Income from Non-Controlling Interests of $22.0 million for Q1 2026, up 69.23% on a QoQ basis from $13.0 million in Q4 2025, and down 8.33% year-over-year from $24.0 million in Q1 2025.
GE HealthCare Technologies (GEHC) Income from Non-Controlling Interests (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' Income from Non-Controlling Interests history runs 5 years deep, the most recent figure standing at $22.0 million for Q1 2026.
- Quarterly Income from Non-Controlling Interests fell 8.33% year-over-year to $22.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $67.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $70.0 million, up 22.81% from the prior year.
- Income from Non-Controlling Interests was $22.0 million for Q1 2026 at GE HealthCare Technologies, up from $13.0 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $24.0 million in Q1 2025 and bottomed at $6.0 million in Q3 2022.
- A 5-year average of $14.4 million and a median of $14.0 million in 2024 frame the typical range for Income from Non-Controlling Interests.
- Peak annual rise in Income from Non-Controlling Interests reached 171.43% in 2024, while the deepest fall reached 53.33% in 2024.
- GE HealthCare Technologies' Income from Non-Controlling Interests stood at $19.0 million in 2022, then plunged by 31.58% to $13.0 million in 2023, then surged by 30.77% to $17.0 million in 2024, then dropped by 23.53% to $13.0 million in 2025, then soared by 69.23% to $22.0 million in 2026.
- Business Quant data shows GEHC's Income from Non-Controlling Interests at $22.0 million in Q1 2026, $13.0 million in Q4 2025, and $18.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Steris | 21.43 Bn | 20.99 Bn | 697.10 Mn | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.00 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Sep 30, 2025 | 18.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 24.00 Mn |
| Dec 31, 2024 | 17.00 Mn |
| Sep 30, 2024 | 19.00 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | 13.00 Mn |
| Sep 30, 2023 | 7.00 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Mar 31, 2023 | 11.00 Mn |
| Dec 31, 2022 | 19.00 Mn |
| Sep 30, 2022 | 6.00 Mn |
| Jun 30, 2022 | 13.00 Mn |
| Mar 31, 2022 | 13.00 Mn |